CClinicalTrials.gg
Sign In
Status unknownNCT04411368Updated Jun 2, 2020

Impact of Respiratory Virus in Critically Ill Patients With Acute Respiratory Failure

An observational study in Acute Respiratory Failure and Acute Respiratory Distress Syndrome, sponsored by Seoul St. Mary's Hospital. Status unknown at 1 site in Korea, Republic of. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2020-06-02.

Sponsored by Seoul St. Mary's Hospital · Observational

The sponsor has not verified this record recently (last verified May 2020), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
540
Ages
19 Years and older
Sex
All
01

Study summary

This is an observational study to evaluate the clinical impact of respiratory virus in the patients with acute respiratory failure

02

Conditions studied

  • Acute Respiratory Failure
  • Acute Respiratory Distress Syndrome
03

In context

Respiratory Distress Syndrome

1,597 studies on the registry are indexed under Respiratory Distress Syndrome; 312 are open to participants now.

This study's planned enrollment of 540 is above the median of 100 across 540 observational studies indexed under Respiratory Distress Syndrome.

Browse Respiratory Distress Syndrome studies →

Lead sponsor

Seoul St. Mary's Hospital is the lead sponsor of 71 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Subjects with presentation to ICU with critical illness compatible with acute respiratory failrue.

* Definition of acute respiratory failure: Patients who met one of following criteria

  1. SaO2 \< 90% on room air
  2. SaO2 \< 92% on > 6L/min of oxygen
  3. Respiratory rates > 30/min, or sign of respiratory distress

Inclusion criteria

  • Male or female aged ≥ 19 years
  • Written informed consent by the patient or legally authorized representative
  • Critical illness consistent with acute respiratory failure, to be enrolled within 24 hours of presentation

Exclusion criteria

Exclusion Criteria:

  • No informed consent
  • A patient who is judged to be unable to make a voluntary decision by understanding information about this research due to cognitive vulnerability
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
540 participants (estimated)
Patient registry
No
Biospecimen retention
Samples without dna
06

What researchers measure

Primary outcomes

  1. Rate of respiratory viral infections

    Rate of respiratory viral infections in patients with acute respiratory failure

    Time frame: within 24 hours after intensive care unit (ICU) admission

Secondary outcomes

  1. ICU mortality rate

    Association between respiratory viral infections and death in ICU and risk factors of death in patients with ARF

    Time frame: Through study completion, an average of 1 year

  2. Hospital mortality rate

    Association between respiratory viral infections and death in hospital and risk factors of death in patients with ARF

    Time frame: Through study completion, an average of 1 year

07

Study locations

1 of 1 sites recruiting
  • Seoul St. Mary's Hospital
    Seoul, 06591, Korea, Republic of
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 2, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04411368
Lead sponsor
Seoul St. Mary's Hospital
Responsible party
Jongmin Lee (Assistant professor, Seoul St. Mary's Hospital) — Principal investigator
First posted
Jun 2, 2020
Start date
Jun 1, 2020 (estimated)
Primary completion
Dec 31, 2022 (estimated)
Completion
Dec 31, 2023 (estimated)
Last update
Jun 2, 2020

Study contacts

Jongmin Lee, Ph.D
Contact
dibs03@gmail.com
+821063007128
Jongmin Lee
study director · Seoul St. Mary's Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Respiratory Distress Syndrome→

Other studies from this sponsor

Seoul St. Mary's Hospital

Start the discussion